Compugen CGEN
NASDAQ CGEN
$2.59 +0.03 (+1.37%)
At close: Sep 4, 2026 · 4:00 PM EDT

Compugen (CGEN) Non-Current Deffered Revenue (2013 - 2026)

Compugen (CGEN) posted quarterly Non-Current Deffered Revenue of $22.1 million for Q1 2026, down 30.31% year-over-year from $31.8 million in Q1 2025, and down 11.24% on a QoQ basis from $24.9 million in Q4 2025.

Analysis

Compugen (CGEN) Non-Current Deffered Revenue (2013 - 2026) Analysis & Trends

Compugen has reported Non-Current Deffered Revenue for 6 years, with the latest figure at $22.1 million in Q1 2026.

  • Non-Current Deffered Revenue for Q1 2026 came in at $22.1 million, down 30.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.1 million (down 30.31% YoY), and the FY2025 annual result was $24.9 million, down 26.74% from the prior year.
  • Non-Current Deffered Revenue declined to $22.1 million in Q1 2026, from $24.9 million in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $34.0 million in Q4 2024 and troughed at $21.0 million in Q2 2024.
  • A 4-year average of $26.9 million and a median of $26.5 million in 2023 frame the typical range for Non-Current Deffered Revenue.
  • The widest annual swing landed in 2025, when Non-Current Deffered Revenue jumped 40.73%; it then slumped 30.31% in 2026.
  • A 4-year view of Non-Current Deffered Revenue shows it stood at $25.4 million in 2023, then surged by 34.08% to $34.0 million in 2024, then decreased by 26.74% to $24.9 million in 2025, then slipped by 11.24% to $22.1 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $22.1 million in Q1 2026, $24.9 million in Q4 2025, and $27.6 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 220.40 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 147.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Compugen 242.44 Mn 156.82 Mn -92,000.00 20.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.36 Mn
Mar 31, 2026 22.14 Mn
Dec 31, 2025 24.94 Mn
Sep 30, 2025 27.57 Mn
Jun 30, 2025 29.59 Mn
Mar 31, 2025 31.77 Mn
Dec 31, 2024 34.05 Mn
Sep 30, 2024 29.24 Mn
Jun 30, 2024 21.03 Mn
Mar 31, 2024 23.23 Mn
Dec 31, 2023 25.39 Mn
Sep 30, 2014 326,000.00
Jun 30, 2014 948,000.00
Dec 31, 2013 1.45 Mn
Sep 30, 2013 2.72 Mn